* InspireMD Inc NSPR.OQ reported a quarterly adjusted loss
of 53
cents per share for the quarter ended in December. The lone
analyst forecast for the quarter was for a loss of 78 cents per
share.
* Revenue rose 773.4% to $1.38 million from a year ago;
analysts
expected $1.30 million.
* InspireMD Inc's reported EPS for the quarter was a loss
of 53
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* InspireMD Inc shares had fallen by 12.9% this quarter.
* The company reported a quarterly loss of $4.1 million.
* Wall Street's median 12-month price target for InspireMD
Inc is
$9.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated March 8 at 02:31 p.m. All
figures in US dollars unless otherwise stated